Higgins P M, Bennett-Jones D N, Naish P F, Aber G M
Department of Urology, North Staffordshire Hospital Centre, Stoke-on-Trent, UK.
Br J Surg. 1988 Jun;75(6):573-7. doi: 10.1002/bjs.1800750625.
It is generally recognized that in many patients the ureteric obstruction and other manifestations of non-malignant retroperitoneal fibrosis will respond to treatment with corticosteroids. However, most surgeons are reluctant to use steroids as the primary treatment for patients with this condition, mainly because of the risk of mismanagement of malignant retroperitoneal fibrosis. Our experience in the care of 17 patients with non-malignant retroperitoneal fibrosis has led us to believe that an initial non-surgical approach is both safe and preferable.
人们普遍认识到，在许多患者中，输尿管梗阻及非恶性腹膜后纤维化的其他表现对皮质类固醇治疗有反应。然而，大多数外科医生不愿将类固醇作为这种疾病患者的主要治疗方法，主要是因为存在误诊恶性腹膜后纤维化的风险。我们对17例非恶性腹膜后纤维化患者的护理经验使我们相信，初始的非手术方法既安全又可取。
